Page 103 - MEMORIA_SEHH-FEHH_2023

MEMORIA ANUAL 2023
SOCIEDAD ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
PETHEMA
FUNDACIÓN ESPAÑOLA DE
HEMATOLOGÍA Y HEMOTERAPIA
El Chaer F, Fathi AT, Freeman SD, Gojo I, Grunwald MR, Jonas BA, Konopleva M, Lin TL,
Mannis GN, Mascarenhas J, Michaelis LC, Mims AS, Montesinos P, Pozdnyakova O, Pratz
KW, Schuh AC, Sekeres MA, Smith CC, Stahl M, Subklewe M, Uy GL, Voso MT, Walter RB,
Wang ES, Zeidner JF, Žučenka A, Zeidan AM.
• Molecular Landscape and Validation of New Genomic Classification in 2668 Adult
AML Patients: Real Life Data from the PETHEMA Registry.
Cancers (Basel). 2023;15(2):438. doi: 10.3390/cancers15020438.
Sargas C, Ayala R, Larráyoz MJ, Chillón MC, Carrillo-Cruz E, Bilbao-Sieyro C, Prados de
la Torre E, Martínez-Cuadrón D, Rodríguez-Veiga R, Boluda B, Gil C, Bernal T, Bergua JM,
Algarra L, Tormo M, Martínez-Sánchez P, Soria E, Serrano J, Alonso-Domínguez JM, Gar-
cía-Boyero R, Amigo ML, Herrera-Puente P, Sayas MJ, Lavilla-Rubira E, Martínez-López
J, Calasanz MJ, García-Sanz R, Pérez-Simón JA, Gómez-Casares MT, Sánchez-García J,
Barragán E, Montesinos P, On Behalf Of Pethema Group.
• Incidence and Risk Factors for Development of Cardiac Toxicity in Adult Patients
with Newly Diagnosed Acute Myeloid Leukemia.
Cancers (Basel). 2023;15(8):2267. doi: 10.3390/cancers15082267.
Boluda B, Solana-Altabella A, Cano I, Martínez-Cuadrón D, Acuña-Cruz E, Torres-Miñana
L, Rodríguez-Veiga R, Navarro-Vicente I, Martínez-Campuzano D, García-Ruiz R, Lloret
P, Asensi P, Osa-Sáez A, Aguero J, Rodríguez-Serrano M, Buendía-Fuentes F, Megías-
Vericat JE, Martín-Herreros B, Barragán E, Sargas C, Salas M, Wooddell M, Dharmani C,
Sanz MA, De la Rubia J, Montesinos P.
• Identifying prognostic gene panels in acute myeloid leukemia.
Expert Rev Hematol. 2023;16(4):277-87. doi: 10.1080/17474086.2023.2193322.
Sánchez-García J, Serrano J, Prados de La Torre E, Serrano-López J, Aparicio-Pérez C,
Barragán E, Montesinos P.
• Real-world experience with CPX-351 in high-risk acute myeloid leukemia.
Crit Rev Oncol Hematol. 2023;185:103984. doi: 10.1016/j.critrevonc.2023.103984.
Lemoli RM, Montesinos P, Jain A.
• Drug-drug interactions associated with FLT3 inhibitors for acute myeloblastic leuke-
mia: current landscape.
Expert Rev Clin Pharmacol. 2023;16(2):133-48. doi: 10.1080/17512433.2023.2174523.
Solana-Altabella A, Megías-Vericat JE, Ballesta-López O, Martínez-Cuadrón D, Montesi-
nos P.
103